Aspirin, sulindac and the rectum in familial adenomatous polyposis

被引：0
|
作者：
Mills, SJ
Mathers, JC
Chapman, PD
Burn, J
Gunn, A
机构：
[1] Dept Biol Sci, Ashington, England
[2] Dept Nutr Sci, Ashington, England
[3] Wansbeck Dist Gen Hosp Trust, Ashington, England
[4] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
BRITISH JOURNAL OF SURGERY | 1998年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
下载
收藏
页码：55 / 56
页数：2
相关论文
共 50 条
  • [21] Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis
    Guldenschuh, L
    Hurlimann, R
    Muller, A
    Ammann, R
    Mullhaupt, B
    Dobbie, Z
    Zala, GF
    Flury, R
    Seelentag, W
    Roth, J
    Meyenberger, C
    Fried, M
    Hoppeler, T
    Spigelman, AD
    Scott, RJ
    DISEASES OF THE COLON & RECTUM, 2001, 44 (08) : 1090 - 1097
  • [22] Aspirin and Familial Adenomatous Polyposis: Coming Full Circle
    Chan, Andrew T.
    CANCER PREVENTION RESEARCH, 2011, 4 (05) : 623 - 627
  • [23] Sulindac resistant adenomas in familial adenomatous polyposis patients: A molecular evaluation
    Keller, JJ
    Offerhaus, JA
    Drillenburg, P
    Caspers, E
    Musler, A
    Ristimaki, A
    Hylind, LM
    Romans, KE
    Giardiello, FM
    GASTROENTEROLOGY, 2001, 120 (05) : A300 - A300
  • [24] SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS - INTERIM RESULTS OF A PROSPECTIVE-STUDY
    MULLER, A
    HURLIMANN, R
    MEYENBERGER, C
    STAUB, P
    KOBLER, E
    AMMANN, R
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 124 (15) : 651 - 654
  • [25] Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis
    Keller, JJ
    Offerhaus, GJA
    Drillenburg, P
    Caspers, E
    Musler, A
    Ristimäki, A
    Giardiello, FM
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4000 - 4007
  • [26] Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis
    Bowen, Charles M.
    Walter, Lewins
    Borras, Ester
    Wu, Wenhui
    Ozcan, Zuhal
    Chang, Kyle
    Bommi, Prashant, V
    Taggart, Melissa W.
    Thirumurthi, Selvi
    Lynch, Patrick M.
    Reyes-Uribe, Laura
    Scheet, Paul A.
    Sinha, Krishna M.
    Vilar, Eduardo
    CANCER PREVENTION RESEARCH, 2021, 14 (09) : 851 - 862
  • [27] SULINDAC THERAPY FOR FAMILIAL ADENOMATOUS POLYPOSIS AFTER COLECTOMY AND ILEORECTAL ANASTOMOSIS
    MAKELA, JT
    LAITINEN, S
    ANNALES CHIRURGIAE ET GYNAECOLOGIAE, 1994, 83 (03) : 265 - 267
  • [28] Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac
    Nugent, KP
    Spigelman, AD
    Phillips, RKS
    DISEASES OF THE COLON & RECTUM, 1996, 39 (06) : 659 - 662
  • [29] Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis
    Winde, G
    Schmid, KW
    Brandt, B
    Muller, O
    Osswald, H
    DISEASES OF THE COLON & RECTUM, 1997, 40 (10) : 1156 - 1168
  • [30] Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac
    Keller, JJ
    Offerhaus, GJA
    Polak, M
    Goodman, SN
    Zahurak, ML
    Hylind, LM
    Hamilton, SR
    Giardiello, FM
    GUT, 1999, 45 (06) : 822 - 828
12345